Long-term follow-up after gentamicin application via the Siverstein MicroWick in the treatment of Ménière's disease

Ear, Nose and Throat Journal

Volumn 85, Issue 8, 2006, Pages 494-498

  Hill III, Samuel L ^a   Digges, E Nicholas B ^a   Silverstein, Herbert ^a   Moss, Jennifer ^a  

^a Ear Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; AUDIOMETRY; COCHLEA FENESTRA; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTRONYSTAGMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENIERE DISEASE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TELEPHONE; TREATMENT DURATION; TREATMENT RESPONSE; VERTIGO; DRUG DELIVERY SYSTEM; DRUG EFFECT; EARDRUM; MIDDLE AGED; TIME; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG DELIVERY SYSTEMS; FEMALE; GENTAMICINS; HUMANS; MALE; MENIERE'S DISEASE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TYMPANIC MEMBRANE; VERTIGO;

EID: 33750630465     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130608500811     Document Type: Article

References (17)

1. Schuknecht HF. Ablation therapy for the relief of Meniere's disease. Laryngoscope 1956;66:859-70.
2. Jackson LE, Silverstein H. Chemical perfusion of the inner ear. Otolaryngol Clin North Am 2002;35:639-53.
3. Nedzelski JM, Schessel DA, Bryce GE, Pfleiderer AG. Chemical labyrinthectomy: Local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992;13:18-22.
4. Silverstein H, Arruda J, Rosenberg SI, et al. Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 1999;120:649-55.
5. Light JP, Silverstein H, Jackson LE. Gentamicin perfusion vestibular response and hearing loss. Otol Neurotol 2003;24:294-8.
6. Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000;110:236-40.
7. Corsten M, Marsan J, Schramm D, Robichaud J. Treatment of intractable Meniere's disease with intratympanic gentamicin: Review of the University of Ottawa experience. J Otolaryngol 1997;26:361-4.
8. Schoendorf J, Neugebauer P, Michel O. Continuous intratympanic infusion of gentamicin via a microcatheter in Meniere's disease. Otolaryngol Head Neck Surg 2001;124:203-7.
9. Youssef TF, Poe DS. Intratympanic gentamicin injection for the treatment of Meniere's disease. Am J Otol 1998;19:435-42.
10. Toth AA, Parnes LS. Intratympanic gentamicin therapy for Meniere's disease: Preliminary comparison of two regimens. J Otolaryngol 1995;24:340-4.
11. Diamond C, O'Connell DA, Hornig JD, Liu R. Systematic review of intratympanic gentamicin in Meniere's disease. J Otolaryngol 2003;32:351-61.
12. Hillman TA, Chen DA, Arriaga MA. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease. Laryngoscope 2004;114:216-22.
13. Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Meniere's Disease. Otol Neurotol 2003;24:800-6.
14. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Surgery, Inc. Otolaryngol Head Neck Surg 1995;113:181-5.
15. Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Meniere's disease. Otolaryngol Head Neck Surg 1989;100:6-16.
16. Quaranta A, Marini F, Sallustio V. Long-term outcome of Meniere's disease: Endolymphatic mastoid shunt versus natural history. Audiol Neurootol 1998;3:54-60.
17. Hone SW, Nedzelski J, Chen J. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation? J Otolaryngol 2000;29:83-7.